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Introduction
As the population of older individuals grows in developed 
countries, there is increasing need for surgical treatment of 
age-related compressive spinal cord lesions and spinal cord 
injuries. However, the way that aging affects the spinal cord at 
a molecular level is unclear, as evidenced by several contradic-
tory reports describing the influence of aging on spinal cord 
lesions. For example, several studies reported that there was 
no significant difference between the neurological recovery of 
older and younger patients after surgical decompression for 
cervical myelopathy.1,2 In contrast, other reports described a 
worse outcome after decompression surgery for cervical mye-
lopathy in elderly patients.3 Moreover, neurological outcomes 
of spinal cord injury (SCI) in aged patients are reported to be 
worse than those of younger patients.4 Thus, to elucidate the 
influences of aging on the spinal cord, an in-depth under-
standing of the pathological mechanisms of spinal cord aging 
is essential.
The aim of this study was to explore spinal cord aging–
related proteins that may be involved in pathological mecha-
nisms of age-related changes in the spinal cord. Previous report 
showed the results of proteomic analyses of aging-related 
changes in the brain of animals and humans.5 For the first time, 
we show the results of proteomic comparison between aged 
and young rat spinal cord.
Materials and Methods
Animals
All animals were treated and cared for in accordance with the 
Chiba University School of Medicine guidelines that pertain 
to the treatment of experimental animals. This study was 
approved by the Animal Care and Use Committee of Chiba 
University Graduate School of Medicine (Approval Number 
27-91).
Two-year old and 8-week-old female Sprague-Dawley 
(SD) rats ( Japan SLC, Inc. Hamamatsu, Japan) were used as 
models of aged and young animals, respectively. Animals were 
euthanized with pentobarbital overdose.
Sample preparation
Thoracic spinal cords (1 cm length) were dissected from the 
animals and after snap-freezing in liquid nitrogen were pre-
served at −80°C until use. Samples were thoroughly ground 
and dissolved with Dissolve buffer (8 M urea, 4% 3-[(3-chola-
midopropyl) dimethylammonio] propanesulfonate [CHAPS], 
60 mM dithiothreitol [DTT], 10 mM Tris-HCl [pH 7.4]). 
Dissolved samples were cleaned with a 2-dimensional Clean 
Up kit (Bio-Rad, Hercules, CA), redissolved in sample buffer 
(7 M urea, 2% CHAPS, 20 mM DTT, 2 mM Tris-(2-
cyanoethyl) phosphine, 0.2% BioLyte 3-10 [Bio-Rad]), and 
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the protein concentration was measured by the Bradford 
method.
Two-dimensional polyacrylamide gel electrophoresis
Protein samples (30 µg) from each rat were applied to an 
immobilized pH gradient (IPG) gel (IPG ReadyStrip 7 cm, 
pH 3-10; Bio-Rad) for isoelectric focusing. Next, equilibration 
was performed with equilibration buffer (50 mM Tris-HCl 
[pH 8.5], 6 M urea, 30% glycerol, 2% sodium dodecyl sulfate 
[SDS], 1% DTT, 0.005% bromophenol blue) for 15 minutes 
and then re-equilibrated with a second equilibration buffer (50 
mM Tris-HCl [pH 8.5], 6 M urea, 30% glycerol, 2% SDS, 
4.5% iodoacetamide, 0.005% bromophenol blue) for 15 min-
utes. After equilibration, IPG gels were subjected to 12.5% 
SDS polyacrylamide gel electrophoresis (PAGE) under reduc-
ing conditions.
Protein spots were stained with SYPRO Ruby (Thermo 
Fisher Scientific, Waltham, MA) and the gel images were cap-
tured with Molecular Imager FX (Bio-Rad).
Mass spectrometry
Protein spots showing a 2-fold or greater difference between 
aged and young rats were isolated and identified using mass 
spectrometry (MS). Identified spots on the gels were automati-
cally detected by Melanie 4.02 software, excised with a 
Proteineer spII spot picker (Bruker Daltonics, Bremen, 
Germany), and dried in a speed vacuum concentrator (MaxiDry 
Plus, Heto, Allered, Denmark). Each dried gel piece was rehy-
drated with 5 µL of 1 mM ammonium bicarbonate containing 
50 ng trypsin (Roche Diagnostics, Basel, Switzerland) and 
incubated in the dark overnight at room temperature. Then, 20 
µL of 50% acetonitrile containing 0.3% trifluoroacetic acid was 
added to each gel and incubated for 15 minutes with constant 
shaking. The peptide mixture (1.5 µL) was simultaneously 
applied to 1 µL of matrix solution consisting of 0.025% 
α-cyano-4-hydroxycinnamic acid (Merck Millipore, Billerica, 
MA), standard peptides des-Arg-bradykinin (Merck Millipore, 
904.4681 Da), and adrenocorticotropic hormone fragment 18 
to 39 (Merck Millipore, 2465.1989 Da) in 65% ethanol, 35% 
acetonitrile, and 0.03% trifluoroacetic acid. Samples were ana-
lyzed for peptide mass fingerprinting with matrix-assisted laser 
desorption/ionization (MALDI)-MS in a time-of-flight mass 
spectrometer (Ultraflex II; Bruker Daltonics). Matching pep-
tide and protein searches were performed automatically. Each 
spectrum was interpreted using Mascot Software (Matrix 
Sciences Ltd., London, UK). For peptide identification, monoi-
sotopic masses were used and a mass tolerance of 0.0025% 
(25 ppm) was allowed. Unmatched peptides or peptides with up 
to 1 missed cleavage site were excluded from further considera-
tion. The peptide masses were compared with the theoretical 
peptide masses of all available proteins from all species using 
SWISS-PROT, international protein index (IPI), and Mass 
Spectrometry Sequence Database (MSDB) databases.
Western blot analysis
Frozen spinal cord samples were homogenized in 50 mM Tris-
HCl (pH 7.4), 150 mM NaCl, and 1% Triton X-100 (homog-
enization buffer) containing a protease inhibitor cocktail 
(cOmplete; Roche Diagnostics). The homogenates were cen-
trifuged at 10 000g for 10 minutes at 4°C to remove cellular 
debris. Protein concentrations of the supernatants were meas-
ured using the Bradford method and adjusted to 1 mg/mL by 
dilution with homogenization buffer. Protein samples were 
mixed with an equal volume of concentrated (2×) sample 
buffer: 250 mM Tris-HCl, 4% SDS, 20% glycerol, 0.02% 
bromophenol blue, and 10% β-mercaptoethanol. After boiling 
for 5 minutes, equal volumes of samples were subjected to 
10% SDS-PAGE under reducing conditions, and the proteins 
were transferred to a polyvinylidene difluoride membrane 
(Immobilon-P; Merck Millipore). After blocking, the mem-
brane was reacted with an anti–αB-crystallin (1: 1000; 
Merck Millipore), anti-peripherin (1: 1000; Novus Biologicals, 
Littleton, CO), and an anti–β-actin antibody as a loading 
control (1: 1000; Santa Cruz Biotechnology, Santa Cruz, CA). 
For detection, a horseradish peroxidase–conjugated secondary 
antibody (1: 2500; Cell Signaling Technology, Danvers, MA) 
and an ECL chemiluminescence system (GE Healthcare, 
Piscataway, NJ) were used. Western blot analysis was per-
formed in triplicate for each sample. Protein bands were quan-
tified using ImageJ (National Institutes of Health) software 
and digital quantification was performed, and densitometry 
results calculated as mean expression level in old rats were 
expressed as the ratio compared with that in young rats.
Immunohistochemistry
Tissues from a subset of rats (n = 4/group) were prepared for 
histological evaluation. Animals were anesthetized with pento-
barbital and perfused transcardially with 4% paraformaldehyde 
in phosphate-buffered saline (PBS, pH 7.4). Tissue blocks of the 
thoracic spinal cord were removed, post-fixed overnight in 4% 
paraformaldehyde, and stored at 4°C in 20% sucrose in PBS 
before embedding in optimum cutting temperature compound 
(Sakura Finetechnical, Tokyo, Japan). The cryoprotected samples 
were frozen and were cut into serial 20 µm transverse sections.
For immunofluorescent labeling, sections were permeated 
with 0.3% Triton X in PBS and treated for 1 hour in blocking 
solution containing 1% bovine serum albumin. Sections were 
then incubated with the following primary antibodies: rabbit 
polyclonal anti–αB-crystallin antibody (1:400), mouse mono-
clonal peripherin antibody (1: 400), and anti-neurofilament 
200 rabbit polyclonal antibody (NF200, 1: 400; Merck 
Millipore) for nerve fibers and anti–adenomatous polyposis 
coli (APC) mouse monoclonal antibody (1: 400; Abcam plc, 
Cambridge, UK) for oligodendrocytes. The sections were 
incubated with primary antibodies overnight at 4°C and then 
washed in PBS before incubation for 1 hour at room tempera-
ture with the secondary antibodies: Alexa 488– or Alexa 
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594–labeled anti-mouse, anti-rabbit IgG (1:800; Fisher 
Scientific, Inc.). Finally, the sections were washed twice in 
PBS and protected with coverslips. Positive labeling was 
observed using fluorescence microscopy (ECLIPSE E600; 
Nikon, Tokyo, Japan). To determine the specificity of staining, 
procedures were performed on control sections with the omis-
sion of primary or secondary antibodies.
Statistical analyses
Results of Western blot analyses were subjected to Student t 
test to compare the difference between the 2 groups.
Results
Through the screening by 2-dimensional PAGE followed by 
MS, several proteins were detected as upregulated proteins in 
aged rat spinal cord (Figure 1; Table 1). Among the screened 
proteins, we selected α-crystallin B-subunit (αB-crystallin) 
and peripherin for further investigation because these proteins 
were previously reported to be related to central nervous sys-
tem (CNS) pathologies.
Immunohistochemistry revealed that peripherin expression 
was detected in posterior horn neurons and nerve fibers in the 
posterior root (Figure 2A to F) and αB-crystallin expression 
was observed in APC-positive oligodendrocytes in spinal cord 
white mater (Figure 2G to L). The spatial expression pattern of 
αB-crystallin and peripherin revealed by immunohistochemis-
try was similar between aged and young rats, although the 
degree of expression was weaker in young rat spinal cord com-
pared with that in old rat spinal cord (Figure 2C, F, I, and L). 
Western blotting revealed significant upregulation of periph-
erin and αB-crystallin expression in aged rat spinal cord (Figure 
2M and N).
Discussion
α-crystallin B-subunit is a small heat shock protein that acts as 
a molecular chaperone. The expression and chaperone activity 
of αB-crystallin in the lens of the eye likely contribute to the 
long-term maintenance of lens clarity.6 In other tissues, αB-
crystallin exerts molecular chaperone function and has an 
antiapoptotic function.7 In terms of CNS pathologies, αB-
crystallin activity has a protective effect during brain aging.8 
Indeed, Klopstein et al9 reported a beneficial effect of αB-
crystallin for a mouse model of SCI. They also provide evi-
dence that recombinant human α-crystallin modulates the 
inflammatory response in the injured spinal cord. Inflammation 
is known to be related to the aging process in various organs, 
tissues, and systems, including the CNS10 where dysregulation 
of microglia, the resident immune cells in the CNS, is report-
edly associated with age-related pathologies. In the same con-
text, upregulation of inflammatory cytokines is known to occur 
in spinal cord tissue from aged dogs.11 Moreover, aged rats 
showed poor recovery from SCI due to increased numbers of 
activated microglia.12 Together, these lines of evidence suggest 
that the pathological changes in the aged spinal cord might 
restrict neurological recovery. Thus, upregulation of αB-
crystallin expression in aged spinal cord might counteract 
inflammatory reaction–related aging processes by modulating 
inflammation.13
Figure 1. Result of 2-dimensional polyacrylamide gel electrophoresis (2D-PAGE). Protein samples obtained from young (left panel) and aged (right 
panel) rat spinal cords were subjected to 2D-PAGE. Protein spots showing upregulation in old rats were then subjected to mass spectrometry to detect 
protein.
Table 1. List of detected proteins by mass spectrometry (P < .05).
PROTEIN TOTAL SCORE
Upregulated in old rat spinal cord
 Glial fibrillary acidic protein 450
 Glial fibrillary acidic protein 442
 Neurofilament medium 439
 Peripherin 436
 α-crystallin B-subunit 434
downregulated in old rat spinal cord
 Major beta-hemoglobin 432
 Hemoglobin subunit alpha-1/2 392
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Peripherin is a type III intermediate filament protein that is 
mainly expressed in neurons of the peripheral nervous sys-
tem.14 Although peripherin is thought to play a role in neurite 
elongation during development and axonal regeneration after 
injury, its exact function is unknown. Peripherin is also associ-
ated with some of the major neuropathologies that characterize 
amyotrophic lateral sclerosis. Aggregates of peripherin have 
been shown to induce neuronal death15 and that cells can be 
rescued from peripherin-induced cell death by overexpression 
of the neurofilament heavy chain.16 These lines of evidence 
suggest that peripherin can potentially act as a toxic agent in 
the spinal cord and that the peripherin upregulation seen in 
aged rat spinal cord in this study might reflect aging-related 
deposition of toxic products.17
The precise mechanisms underlying the upregulation of 
αB-crystallin and peripherin protein expression in spinal cord 
of aged animals are still unclear. Although further exploration 
is needed to elucidate the precise mechanism and potential role 
of these upregulated proteins in spinal cord aging processes, 
inflammatory reactions and deposition of toxic products might 
be factors in inducing aging-related spinal cord tissue damage 
and vulnerability to injuries caused by external force.
Precise understanding of molecular basis of spinal cord 
aging is essential for clarification of aging-related spinal cord 
vulnerability. Although further exploration is needed, this study 
is the very first step toward explication of spinal cord aging.
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